[<sup>89</sup>Zr]Zr-anti-CD8-IgG2a<sub>silent</sub> might be suited for TME immunophenotyping, while <i>ex vivo</i> labeling visualizes tumor migration and invasion dynamics of tumor-specific T cells. Here, CD8A is linked to neoplasm.